Loading...

Table of Content

    20 October 2014, Volume 9 Issue 10
    Gradients
    WANG Yong-Jun
    2014, 9(10):  807-810. 
    Asbtract ( )   PDF (3935KB) ( )  
    References | Related Articles | Metrics
    Cerebral Venous Thrombosis: Risk factors, Diagnosis and Treatment
    PENG Bin
    2014, 9(10):  811-813. 
    Asbtract ( )   PDF (1720KB) ( )  
    References | Related Articles | Metrics
    Clinical and Imaging Features in Deep Cerebral Venous Thrombosis:an Analysis of 12
    Cases
    ZHOU Yan, NI Jun, ZHU Yi-Cheng, ZHOU Li-Xin, YAO Ming, GUAN Hong-Zhi,
    2014, 9(10):  814-818. 
    Asbtract ( )   PDF (2519KB) ( )  
    References | Related Articles | Metrics

    Objective To discuss the clinical and imaging features of deep cerebral venous thrombosis (DCVT). Methods The clinical and imaging features, treatments as well as outcomes of 12 patients with DCVT confirmed by magnetic resonance venography (MRV) or digital subtraction angiography (DSA) were analyzed retrospectively. All patients were admitted to Peking Union Medical College Hospital between December 2004 and May 2013. Results Seven of 12 patients were male, 5 were female. The median age of all 12 patients was 24.5 (19.75, 33.5) years. Clinical presentations:headache (11/12, 92%), reduced consciousness (5/12, 42%), seizures (5/12, 42%), other focal neurological signs (2/12, 17%). Imaging findings:Within the deep venous system (DVS), the straight sinus and Galen vein were affected most frequently in 11 (11/12 [92%]) and 8 (8/12 [67%]) patients respectively, internal cerebral veins were affected in 3 (3/12, 25%), whereas basal veins were less frequently involved (1/12, 8%). All patients were associated with thrombosis of other sinuses. Among the eight patients who underwent computed tomography (CT) and/or magnetic resonance imaging (MRI) examination, the parenchymal findings included thalamic lesions (4/8, 50%), basal ganglia lesions (2/8, 25%), and frontal or parietal lobe lesions (3/8, 38%). Intracerebral hemorrhage was seen in two patients (2/8, 25%). Treatment and outcome:All patients received anticoagulation therapy except one who was diagnosed septic shock and died finally. Eleven of the 12 patients had excellent outcome on discharge. The parenchymal lesions improved or disappeared in the follow-up image series. Conclusion Consciousness impairment and bilateral thalamic lesions were the common clinical and parenchymal MRI presentations in patients with DCVT. The straight sinus and Galen vein were affected most frequently. DCVT was usually in association with thrombosis of other sinuses. Early diagnosis and timely treatment may improve prognosis despite the severe manifestations on acute stage.

    Treatment Strategies for Pregnancy with Cerebral Venous Sinus Thrombosis
    NIU Jing-Wen, NI Jun, YAO Ming, ZHOU Li-Xin, DAI Yi, FAN Si-Yuan, ZHU Yi-Cheng, PENG Bin, CUI Li-Ying.
    2014, 9(10):  819-823. 
    Asbtract ( )   PDF (3353KB) ( )  
    References | Related Articles | Metrics

    Objective To discuss the possible cause, clinical symptoms, radiologic characteristics, diagnosis and our treatment strategies of cerebral venous sinus thrombosis (SCVT) in pregnancy. Methods We presented 12 cases of pregnancy with emergent SCVT admitted between 1993 and 2013 in the Department of Neurology, Peking Union Medical College (PUMC) hospital. The average age was (26±5) (19~34). Computed tomography (CT)/magnetic resonance imaging (MRI) was performed in all 12 patients in acute/subacute period; magnetic resonance venography (MRV) in 9 and digital subtraction angiography (DSA) in 6. The possible pathogenesis, clinical symptoms, radiological findings, diagnosis and treatment strategies were discussed. Results Of the 12 pregnant or maternity patients with SCVT, 7 got the disease in early pregnancy, 1 in late pregnancy, 4 within 2 weeks after delivery, 1 after abortion. The accompanied diseases were:one with protein S deficiency, one with hyperhomocystinemia, one with idiopathic thrombocytopenia purpura, one with infection, one with anemia. Clinical onset was acute or subacute. Twelve patients had headache, 5 had epilepsy, 5 had focal neurological signs (including weakness, Babinski signs, numbness, ataxia, peripheral facial paralysis), 1 had visual loss, 4 had disturbance of consciousness. All 12 patients had MRI during acute or subacute period, 9 had abnormal parenchymal signals--7 had infarction or hemorrhagic infarction, 1 had cerebral hemorrhage, and 1 had cerebral edema. Transverse sinus and sigmoid sinus were involved in 9 cases, superior sagittal sinus in 8, straight sinus and inferior sagittal sinus in 2, jugular vein in 2. Treatment:pregnancy was timely terminated in 6 pregnant patients; 1 patient whose family disagreed to terminate pregnancy aggravated and went back home. Ten patients accepted heparinized anti-coagulation as soon as possible, and all of them got better when they were discharged. Conclusion When pregnant women had acute/subacute headache, epilepsy and other local signs, the possibility of SCVT should be suspected. Abnormal parenchymal signals in draining area of venous sinus (especially hemorrhagic infarction) could be a clue to diagnosis. Timely termination of pregnancy and anti-coagulation could lead to a good prognosis.

    Effects of Xiaoshuan Enteric-coated Capsule on Astrocyte Activation and Expression of
    Caspase-3, PARP in Remote Encephalic Region of MCAO Rats
    WANG Ya-Li*, ZHANG Ning, LIU Jing, WU Xi, WANG Lei, ZHAO Hui.
    2014, 9(10):  824-830. 
    Asbtract ( )   PDF (3864KB) ( )  
    References | Related Articles | Metrics

    Objective To investigate the effects of Xiaoshuan enteric-coated capsule on astrocyte activation and expression of cystein-aspartate protease 3 (Caspase-3), poly ADP-ribose polymerase (PARP) in middle cerebral artery occlusion (MCAO) rats of remote encephalic region. Methods The study adopted the animal model of MCAO. Xiaoshuan enteric-coated capsule (420, 140, 47 mg/kg) was given orally to rats once each day for 15 d after ischemia. Bar-grasping was measured at 3 d, 7 d, 12 d and 15 d after ischemia. The expression of glial fibrillary acidic protein (GFAP), Caspase-3 and PARP were detected by using immunofluorescence at 15 d after ischemia. Results Xiaoshuan enteric-coated capsule strengthened the ability of bar-grasping of MCAO rats at 7 d, 12 d and 15 d after ischemia (P <0.05). In addition, Xiaoshuan enteric-coated capsule significantly controlled the positive expression of GFAP and PARP (P <0.01), decreased the numbers of Caspase-3 positive cells (P <0.05) in hippocampus of MCAO rats. Conclusion Xiaoshuan enteric-coated capsule reduces the activation of GFAP, Caspase-3 and PARP. As a result, Xiaoshuan enteric-coated capsule can protect the remote encephalic region of ischemia.

    Assessing the Safety of Selectively Early Administration of Dual Antiplatelet Therapy
    in Patients with Cerebral Infarction after Intravenous Thrombolysis
    WANG Huan,LI Wei, LIU Cheng-Chun, WU Ya, YI Xu, ZHANG Zhi-Hong, LI Xiao-Shu, ZHANG Meng.
    2014, 9(10):  831-836. 
    Asbtract ( )   PDF (2655KB) ( )  
    References | Related Articles | Metrics

    Objective To evaluate the safety of selectively early administration of oral antiplatelet therapy within 1 hour after recombinant tissue type plasminogen activator (rt-PA) treatment in patients with acute ischemic stroke. Methods A total of 112 acute ischemic stroke patients with relatively low hemorrhagic transformation (HT) risk according to multimode imaging and hemorrhage after thrombolysis (HAT) score were selected for this clinical trial from Department of Neurology of The Third Affiliated Hospital of Third Military Medical University, from January 2011 to April 2014. Sixty-six patients were treated with oral 100 mg aspirin and 75 mg clopidogrel within 1 hour after the intravenous rt-PA administration with the informed consent from the patients or their legal representatives. In the other 46 patients, oral antiplatelet therapy started 24 hours after rt-PA treatment according to the will of the patients or their family, who preferred to follow the current guidelines. The primary safety endpoint was the reocclusion in 1 d after the thrombolysis, HT in 3 d, the score of National Institutes of Health Stroke Scale (NIHSS) in 7 d, and the death of the patients. Results There was no significant difference in the baseline (including gender, age, level of blood pressure, blood glucose and cholesterin before thrombolysis, the history of transient ischemic attack or cardiac valvular disease, etc.) between two groups. Importantly, no significant difference was found in HT (7.6% vs 6.5%, P =1.000), while the number of symptomatic intracerebral hemorrhage and death in both groups were zero. We even found decreasing tendency of NIHSS score at 7 d after the thrombolysis (NIHSS=6 vs NIHSS=7, P =0.143) and the frequency of reocclusion (4.5% vs 15.2 %, P =0.107) in early antiplatelet administration group was reduced although no significance was achieved. Conclusion Administration of oral antiplatelet therapy within 1 hour after patients with acute ischemic stroke treated with rt-PA does not increase the risk of HT in the patients screened by multimode imaging and HAT score

    Imaging of Cerebral Venous Thrombosis
    ZHOU Li-Xin, NI Jun, ZHU Yi-Cheng, YAO Ming, PENG Bin, CUI Li-Ying.
    2014, 9(10):  837-845. 
    Asbtract ( )   PDF (4759KB) ( )  
    References | Related Articles | Metrics

    Cerebral venous thrombosis, including thrombosis of cerebral veins and major dural sinuses, is an uncommon disorder in the general population. It may have disastrous consequences if not diagnosed and treated promptly. Imaging plays a primary role in its diagnosis. Magnetic resonance imaging (MRI) of the head combined with magnetic resonance venography (MRV) is the most sensitive study for detection of cerebral venous thrombosis in the acute, subacute, and chronic phases. If the diagnosis is still uncertain after MRI and MRV has been performed, cerebral angiography may be indicated. Knowledge of normal venous variations and potential pitfalls related to image interpretation are important for achieving an accurate diagnosis.

    One Case Report about Paroxysmal Defect of Visual Field due to Subacute Infection
    Endocarditis
    LIU Xin, MI Dong-Hua, QU Hui, et al.
    2014, 9(10):  846-849. 
    Asbtract ( )   PDF (1999KB) ( )  
    References | Related Articles | Metrics
    Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack
    (Part 3)
    HU Hui, GU Xiao-Bo, XIONG Xin-Li, et al.
    2014, 9(10):  850-859. 
    Asbtract ( )   PDF (1804KB) ( )  
    Related Articles | Metrics
    Research Progress in the Diagnosis and Treatment of D-dimer in Cerebral Venous
    Sinus Thrombosis
    CHEN Dan-Li, TUERXUN Shabier,ZHANG Xiang.
    2014, 9(10):  860-863. 
    Asbtract ( )   PDF (1951KB) ( )  
    References | Related Articles | Metrics

    D-dimer is a specific crosslinked fibrin degradation product generated in the action of plasmin. It can not only reflect the activity of thrombin, but also plasmin activity. In recent years, numerous studies have demonstrated that D-dimer increased in the majority of patients with cerebral venous sinus thrombosis (CVST) and it is helpful in its early diagnosis. Abnormally elevated D-dimer may prompt CVST, but whether normal D-dimer can exclude CVST remains controversial. This paper describes the relationship between D-dimer and CVST, and discusses the clinical significance of D-dimer played in the early diagnosis of CVST, treatment and prognosis.

    Research Progress of Correlation between Adenosine Deaminase 2 (ADA2) and Vasculitis
    JU Jun, ZOU Li-Ping.
    2014, 9(10):  864-868. 
    Asbtract ( )   PDF (1967KB) ( )  
    References | Related Articles | Metrics

    The manifestations of vasculitis and vasculopathy are highly varied and have complicated etiology. Recent studies found that part of patients with vasculitis and vasculopathy may be associated with carrying recessively inherited gene mutation in CECR1 (cat eye syndrome chromosome region, candidate 1), encoding adenosine deaminase 2 (ADA2), which resulted in loss of function. The same mutations in CECR1 were found in patients with polyarteritis and vasculitis without being specifically defined in different research, and deficiency of ADA2 was confirmed. As one of adenosine deaminases (ADA), ADA2 functions in adenosine metabolism, and plays an important role both in early embryonic development and in immune system, but at present there is little study in function of ADA2. It is speculated that ADA2 deficiency induces vasculitis through adenosine increase and destruction of vascular endothelial integrity. The pathogenesis that ADA2 deficiency leads to both vasculopathy and vasculitis needs further study. In summary, deficiency of ADA2 may establish a role for ADA in human disease and provide potential diagnostic and therapeutic strategies for vasculitis. In this article, the relationship between ADA2 and vasculitis is reviewed in order to explore the etiology of vasculitis in genetics.

    Effect of Endothelial Progenitor Cell on Angiogenesis after Cerebral Ischemia
    XIE Chen-Chen*, LUO Yong.
    2014, 9(10):  869-873. 
    Asbtract ( )   PDF (2063KB) ( )  
    References | Related Articles | Metrics

    Endothelial progenitor cells (EPC) are the new strategy of angiogenesis which can proliferate, migrate, differentiate and form new vessels. EPC can improve the angiogenesis in cerebral ischemic area, promote the recovery of neurological function, also it can forecast the risk of cardio-cerebrovascular disease. This article will critically review the EPC and the angiogenesis effect after cerebral ischemia.

    New Progress in Transient Ischemic Attack
    HUANG Wei, BI Qi.
    2014, 9(10):  874-879. 
    Asbtract ( )   PDF (2090KB) ( )  
    References | Related Articles | Metrics

    Transient ischemic attack (TIA) is one of the most common ischemic cerebrovascular diseases, but there are still disputes in its diagnosis and treatment. Is magnetic resonance imaging (MRI)/diffusion weighted imaging (DWI) examination necessary in the diagnosis of TIA; whether patients with TIA should be hospitalized; Dual or mono antiplatelet therapy which is better after TIA; what is the best time of anticoagulant treatment after cardiogenic TIA; secondary prevention of TIA is essential, how to offer a proper secondary prevention and avoid misdiagnosis and mistreatment; some special type of TIA is relatively rare, how to diagnose quickly, these issues deserve clinicians’ attention. This paper summarizes the related clinical research, combined with domestic and international guidelines, and also reviews the latest progress on these issues with the aim of helping the clinicians to understand the diagnosis and treatment of TIA more scientifically.

    Vertebral Artery Hypoplasia and Posterior Circulation Ischemic Stroke:from Hypothesis
    to Pathogenesis
    YU Yue*, XU Zi-Qi, LUO Ben-Yan.
    2014, 9(10):  880-884. 
    Asbtract ( )   PDF (2089KB) ( )  
    References | Related Articles | Metrics

    Vertebral artery hypoplasia is a frequent vascular variation of posterior circulation. Emerging evidence suggests that vertebral artery hypoplasia is a risk factor of posterior circulation ischemic stroke, with a morphological correlation between them. This article reviews research progress of vertebral artery hypoplasia and its role in posterior circulation ischemic stroke in order to promote optimization during clinical decision making

    Training of Medical Students’ Innovation Ability in Vascular Neurology
    LI Na, WANG Chun-Xue, ZHAO Xing-Quan
    2014, 9(10):  885-886. 
    Asbtract ( )   PDF (1784KB) ( )  
    References | Related Articles | Metrics
    Multi-teaching Methods to Improve the Effect of Clinical Practice in Cerebrovascular Disease
    LI Zhi-Mei, ZHANG Zai-Qiang, ZHANG Xing-Hu, et al.
    2014, 9(10):  887-888. 
    Asbtract ( )   PDF (1626KB) ( )  
    References | Related Articles | Metrics
    Promoting Medicine Leaping and Effective Development by Cultivating Medical Students with
    Research Characteristics in China
    JI Rui-Jun, WANG Yong-Jun
    2014, 9(10):  888-889. 
    Asbtract ( )   PDF (2165KB) ( )  
    References | Related Articles | Metrics